Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα

European Journal of Immunology

Volumn 42, Issue 8, 2012, Pages 2052-2059

  Sinha, Pratima ^a   Parker, Katherine H ^a   Horn, Lucas ^a   Ostrand Rosenberg, Suzanne ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

Cancer; Cellular immunology; T cell activation; Tumor immunology; Tumor induced immune suppression

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4 RECEPTOR ALPHA; STAT1 PROTEIN; STAT6 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CELL FUNCTION; CELL STIMULATION; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; LUNG ADENOCARCINOMA; MACROPHAGE; MELANOMA B16; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SUPPRESSOR CELL;

ADENOCARCINOMA; ANIMALS; COLONIC NEOPLASMS; FEMALE; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MAMMARY NEOPLASMS, ANIMAL; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYELOID CELLS;

EID: 84864744528     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201142230     Document Type: Article

References (28)

1. Rabinovich, G. A., Gabrilovich, D. and Sotomayor, E. M., Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 2007. 25: 267-296.
2. Gabrilovich, D. I., Ostrand-Rosenberg, S., and Bronte, V., Coordinated regulation of myeloid cells by tumors. Nat. Rev. Immunol. 2012. 12: 253-268.
3. Gabrilovich, D. I. and Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009. 9: 162-174.
4. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P. et al., Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008. 111: 4233-4244.
5. Youn, J. I., Nagaraj, S., Collazo, M. and Gabrilovich, D. I., Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 2008. 181: 5791-5802.
6. Dolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez Gomez, A., Mesa, C., Geilich, M. et al., Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 2010. 40: 22-35.
7. Serafini, P., Borrello, I. and Bronte, V., Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 2006. 16: 53-65.
8. Gallina, G., Dolcetti, L., Serafini, P., De Santo, C., Marigo, I., Colombo, M. P., Basso, G. et al., Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 2006. 116: 2777-2790.
9. Mandruzzato, S., Solito, S., Falisi, E., Francescato, S., Chiarion-Sileni, V., Mocellin, S., Zanon, A. et al., IL4Ralpha +myeloid-derived suppressor cell expansion in cancer patients. J. Immunol. 2009. 182: 6562-6568.
10. Huang, B., Pan, P. Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M. et al., Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006. 66: 1123-1131.
11. Serafini, P., Carbley, R., Noonan, K. A., Tan, G., Bronte, V. and Borrello, I., High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 2004. 64: 6337-6343.
12. Morales, J. K., Kmieciak, M., Knutson, K. L., Bear, H. D. and Manjili, M. H., GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Res. Treat. 123: 39-49.
13. Filipazzi, P., Valenti, R., Huber, V., Pilla, L., Canese, P., Iero, M., Castelli, C. et al., Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 2007. 25: 2546-2553.
14. Bunt, S. K., Sinha, P., Clements, V. K., Leips, J. and Ostrand-Rosenberg, S., Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J. Immunol. 2006. 176: 284-290.
15. Song, X., Krelin, Y., Dvorkin, T., Bjorkdahl, O., Segal, S., Dinarello, C. A., Voronov, E. et al., CD11b+/Gr-1 +immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells. J. Immunol. 2005. 175: 8200-8208.
16. Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S. et al., Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010. 32: 790-802.
17. Sinha, P., Clements, V. K., Fulton, A. M. and Ostrand-Rosenberg, S., Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res. 2007. 67: 4507-4513.
18. Rodriguez, P. C., Hernandez, C. P., Quiceno, D., Dubinett, S. M., Zabaleta, J., Ochoa, J. B., Gilbert, J. et al., Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J. Exp. Med. 2005. 202: 931-939.
19. Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S. and Srikrishna, G., Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol. 2008. 181: 4666-4675.
20. Cheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., Ortiz, M. et al., Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 2008. 205: 2235-2249.
21. Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S. and Carbone, D. P., Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 1998. 92: 4150-4166.
22. Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P. et al., Myeloid suppressor lines inhibit T-cell responses by an NO-dependent mechanism. J. Immunol. 2002. 168: 689-695.
23. Apolloni, E., Bronte, V., Mazzoni, A., Serafini, P., Cabrelle, A., Segal, D. M., Young, H. A. et al., Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. J. Immunol. 2000. 165: 6723-6730.
24. Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M. and Ostrand-Rosenberg, S., Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 2007. 179: 977-983.
25. Sinha, P., Clements, V. K. and Ostrand-Rosenberg, S., Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J. Immunol. 2005. 174: 636-645.
26. Bronte, V., Serafini, P., Mazzoni, A., Segal, D. M. and Zanovello, P., L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 2003. 24: 302-306.
27. Pulaski, B. A. and Ostrand-Rosenberg, S., Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res. 1998. 58: 1486-1493.
28. Nanni, P., de Giovanni, C., Lollini, P. L., Nicoletti, G. and Prodi, G., TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma. Clin. Exp. Metastasis 1983. 1: 373-380.